kriegt ja wirklich nix mit, der Gute, hehehe, hier die PR's und ein paar Fakten zu der neuen Company IHSI. Im Moment noch kein richtiger Handel in USA, aktuell bid 0,16 / ask 1,25 USD (ansonsten poste ich hier nicht mehr, interessiert ja keinen):
Innovative Health Sciences, Inc. Completes First Medical Technology Acquisition
Innovative Health Sciences, Inc. (OTC:IHSI ) today announced that the company has acquired two operating subsidiaries (HealthSonix Medical Inc.; AquaSonix Therapy Canada, Inc.) from HealthSonix Inc. in exchange for 35,356,000 common shares of IHSI.
"Buying the two operating companies from HealthSonix is a strategic move to immediately enhance our shareholder value and represents the first step in our aggressive long term growth plan," explained Chris Winter, President and CEO of Innovative Health Sciences. "Part of our plan is to inject significant additional working capital into the operations of HealthSonix Medical to speed up the product development, distribution and sales over the coming months," stated Winter.
"What attracted us to HealthSonix was the efficacy, quality and unique nature of their products and the sheer size of their target market. Arthritis is the number one cause of pain in North America. As our population ages the biggest gain will be in the 50+ demographic, one that is expected to double over the next 15 to 20 years," said Winter.
This is the first acquisition for IHSI since the name change from Royal Acquisitions and Development, Inc. (RQST - OTCIQ.PK) to Innovative Health Sciences, Inc. (OTC:IHSI). Concurrent with the new acquisition, the Company and PDI Mining, LLC mutually agreed to cancel their agreement. The company has received and accepted the return of the shares put forth for the venture.
Innovative Health Sciences, Inc. (OTC: IHSI) is a Medical Technology Holding company that invests in new, unique Medical Technology companies. The common denominator of the investments is that the companies and their products must show the potential to have a major global impact and present significant growth opportunities.
For more information, please visit www.innovativeHS.com
"Safe harbor" Statement under the Private Securities Litigation Reform Act of 1995: this release includes forward looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as it or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," or other words or phrases of similar import. Similarly, statements in this release that describe our business strategy, outlook, objectives, plans, intentions or goals are also forward looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
PR von HSXI dazu:
HealthSonix Sells Operating Subsidiaries to Innovative Health Sciences
IRVINE, Calif.-- HealthSonix, Inc. (OTC: HSXI)(FWB:H7S) today announced that Innovative Health Sciences, Inc. [OTC: IHSI] has purchased two wholly owned subsidiaries of HealthSonix, Inc. in exchange for 35,356,000 IHSI common shares.
“Selling the two operating companies to Innovative Health Sciences [ www.innovativehs.com ] will immediately allow the companies to resume full operations and get back to implementing their business plan,” said Dieter Doederlein, Vice President Corporate Development for HealthSonix. “As part of the agreement, Innovative Health Sciences has committed to injecting significant working capital into the operations to expedite the delivery of the Gen II hand held enSonix medical devices and to allow us to expand the distribution of the ZingiberRx Joint and Muscle cream” added Doederlein.
All HealthSonix shareholders of record as of July 14, 2008 will receive IHSI shares on a pro rata basis in exchange for their HSXI shares.. The anticipated exchange ratio is .6 IHSI shares for every 1.00 HSXI share. The shares will be distributed to our shareholders in due course.
“Effectively, the current HealthSonix shareholders, as a group, become the majority shareholders in IHSI” said Chris Winter, CEO of Innovative Health Sciences. “Our management and our shareholders are extremely pleased with this acquisition, and we look forward to making our contribution to the immense growth potential and anticipated success of the HealthSonix products”.
Following the completion of the transaction, HealthSonix Inc. will change its name to HSX Holdings Inc.
HSX Holdings, Inc. (formerly HealthSonix, Inc. - HSXI) is a holding company with ownership interest in Innovative Health Sciences, Inc. [IHSI]. All current HSXI shareholders have indirect ownership in IHSI. For more information, please visit www.hsxholdings.com
I’m sure that many of you were concerned over the ‘silence’ since the trading suspension, but we had no choice while we explored various alternatives. With this news, we are confident that your company will grow significantly this year as we strive to put all the regulatory issues behind us and resume concentrating on business development and sales.
The most salient question on your minds must be ‘what happens with your current HSXI shares’? Innovative Health Sciences paid 35 million shares for the acquisition, and these shares are being held by HSX Holdings Inc. on behalf of all HSXI shareholders. They will be assigned in due course on a pro rata basis to all shareholders of record as of July 14, 2008. The anticipated conversion is 1 HSXI share for .6 of IHSI shares.
There is no transparent market for the old HSXI shares. We’ll be looking to delist them from the public markets and eventually dissolve the old HealthSonix company. Depository Trust Company (DTC) continues to show HSXI shares as ‘suspended’, and we would discourage you from attempting any kind of trade on HSXI as we cannot see how these trades would be cleared by the DTC while the suspension is in effect. We will notify you, when appropriate, how the new shares will be transferred to you.
Many of you have also been inquiring about the Gen II hand held device. We suspended product development and manufacturing the day after the SEC suspension because of the uncertainty of our situation. Staff had to be laid off as we had to make sure there was enough working capital for the company to survive until the acceptable solution was finalized. With the new company and the funding in place, all of our programs that had been “mothballed” will be restarted, immediately.
Over the coming weeks, we will keep you posted on the many positive developments as they relate to other subjects you have raised in the past: product development, sales plans etc…. There will be a teleconference call before end of July to answer questions and to address any issues that remain unclear. Please note the new trading symbol “IHSI”. That is your new company [ www.innovativehs.com ].
Thank you for your support during this difficult time. I’m happy to say we made it through, thanks to a dedicated group of managers and business professionals working overtime. The task in front of us was enormous, and we’re happy that it was completed. Some of you felt that it was taking too long, but if you truly assessed the enormity and complexity of the ‘change over’, you would understand that this was accomplished in near record time.
If you have questions that you would like to have answered before the conference call please do not hesitate to call or email at your convenience.
We look forward to a prosperous future for our company and great returns for our stakeholders.
Dieter D. Doederlein
Investor Relations
MANAGEMENT
Chris Winter, President and CEO
Dieter Doederlein, BA, MBA: Vice President Corporate Development
Gerry Hruby, BCom: Vice President Marketing
Capitalization
Outstanding: 49,569,875
Float: 9,712,250
CUSIP: 457670107
Transfer Agent
Holladay Stock Transfer
2939 N. 67th Place
Scottsdale, AZ 85251
Divisions
HealthSonix Medical, Inc.
AquaSonix Therapy Canada
Incorporation
Innovative Health Sciences is a Nevada Corporation
Corporate Head Office
30798 US Highway 19 North
Palm Harbor, Florida
34684
Tel: [727] 490-4370
Fax: [727] 865-5208 |
Thread abonnieren
